Literature DB >> 27766505

Proper balance of omega-3 and omega-6 fatty acid supplements with topical cyclosporine attenuated contact lens-related dry eye syndrome.

Ling Wang1, Xi Chen1, Jingfang Hao1, Lu Yang2.   

Abstract

Essential fatty acids had been applied in the treatment of dry eye syndrome (DES), but the effects of different combinations of fatty acids have not been investigated. 360 long-term contact lens wearers were included in this double-blinded study. Omega-3 and omega-6 fatty acids were combined in different ratios and supplied to the participants that were randomly divided into six groups, and the effects of different essential fatty acids mixture on DES with or without topical cyclosporine were investigated. More than half of long-term contact lens wearers suffered from DES, which were found to be attenuated by oral supplement of properly balanced O3FA and O6FA fatty acid. The topical cyclosporine treatment considerably inhibited the production of cytokines compared to the cyclosporine negative groups, which further relieved DES. Proper balance of omega-3 and omega-6 fatty acid combination significantly alleviated contact lens-related DES.

Entities:  

Keywords:  Dry eye syndrome; Fatty acids; Lens; Omega-3; Omega-6

Mesh:

Substances:

Year:  2016        PMID: 27766505     DOI: 10.1007/s10787-016-0291-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  20 in total

Review 1.  The developing role of cytokines for imaging inflammation and infection.

Authors:  A Signore; E Procaccini; A Annovazzi; M Chianelli; C van der Laken; A Mire-Sluis
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

2.  [International Dry Eye Workshop (DEWS). Update of the disease].

Authors:  R Herrero-Vanrell; A Peral
Journal:  Arch Soc Esp Oftalmol       Date:  2007-12

3.  Dry eye in contact lens wearers as a growing public health problem.

Authors:  Kristijan Pili; Snježana Kaštelan; Mirela Karabatić; Boris Kasun; Borna Čulig
Journal:  Psychiatr Danub       Date:  2014-12       Impact factor: 1.063

4.  Ocular surface assessment in soft contact lens wearers; the contribution of tear osmolarity among other tests.

Authors:  Aurore Muselier-Mathieu; Alain M Bron; Bénigne Mathieu; Maxime Souchier; Françoise Brignole-Baudouin; Niyazi Acar; Lionel Brétillon; Catherine Creuzot-Garcher
Journal:  Acta Ophthalmol       Date:  2013-03-18       Impact factor: 3.761

5.  Dry eye symptoms and signs in long-term contact lens wearers.

Authors:  Snjezana Kastelan; Adrian Lukenda; Jasminka Salopek-Rabatić; Josip Pavan; Marta Gotovac
Journal:  Coll Antropol       Date:  2013-04

6.  Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.

Authors:  Laura Barachetti; Antonella Rampazzo; Carlo M Mortellaro; Stefania Scevola; Brian C Gilger
Journal:  Vet Ophthalmol       Date:  2014-05-05       Impact factor: 1.644

7.  No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye.

Authors:  Sabrina Viau; Bruno Pasquis; Marie-Annick Maire; Cynthia Fourgeux; Stéphane Grégoire; Niyazi Acar; Lionel Bretillon; Catherine P Creuzot-Garcher; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-12-16       Impact factor: 3.117

Review 8.  Is the dry eye contact lens wearer at risk? Yes.

Authors:  M A Lemp
Journal:  Cornea       Date:  1990       Impact factor: 2.651

9.  Impact of dry eye syndrome on vision-related quality of life.

Authors:  Biljana Miljanović; Reza Dana; David A Sullivan; Debra A Schaumberg
Journal:  Am J Ophthalmol       Date:  2007-01-02       Impact factor: 5.258

Review 10.  What is dry eye and what does it mean to the contact lens wearer?

Authors:  Gary N Foulks
Journal:  Eye Contact Lens       Date:  2003-01       Impact factor: 2.018

View more
  5 in total

1.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

2.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

Review 3.  Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis.

Authors:  Julia Prinz; Nicola Maffulli; Matthias Fuest; Peter Walter; Frank Hildebrand; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2022-08-08

Review 4.  Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.

Authors:  Victor J Drew; Ching-Li Tseng; Jerard Seghatchian; Thierry Burnouf
Journal:  Front Med (Lausanne)       Date:  2018-02-23

5.  Beneficial Fatty Acid Ratio of Salvia hispanica L. (Chia Seed) Potentially Inhibits Adipocyte Hypertrophy, and Decreases Adipokines Expression and Inflammation in Macrophage.

Authors:  Subash-Babu Pandurangan; Salah A Al-Maiman; Laila Naif Al-Harbi; Ali A Alshatwi
Journal:  Foods       Date:  2020-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.